✦ LIBER ✦

One-year open-label trial of thalidomide in ankylosing spondylitis

✍ Scribed by Huang, Feng ;Gu, Jieruo ;Zhao, Wei ;Zhu, Jian ;Zhang, Jianglin ;Yu, David Tak Yan

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 109 KB
Volume: 47
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.10396

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results from an open-label extension stu

Results from an open-label extension study of etanercept in ankylosing spondylitis

✍ Davis, John ;Webb, Allison ;Lund, Steven ;Sack, Kenneth 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

COPD ϭ chronic obstructive pulmonary disease. 300 Letters \* RA ϭ rheumatoid arthritis; JRA ϭ juvenile rheumatoid arthritis; ESR ϭ erythrocyte sedimentation rate; CRP ϭ C-reactive protein; VAS ϭ visual analog scale; GH ϭ general health; DAS28 ϭ Disease Activity Score in 28 joints; HAQ ϭ Health Asses

Adalimumab reduces spinal symptoms in ac

Adalimumab reduces spinal symptoms in active ankylosing spondylitis: Clinical and magnetic resonance imaging results of a fifty-two–week open-label trial

✍ Hildrun Haibel; Martin Rudwaleit; Henning C. Brandt; Zarho Grozdanovic; Joachim 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

Maintenance of infliximab treatment in a

Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one-year randomized controlled trial comparing systematic versus on-demand treatment

✍ Maxime Breban; Philippe Ravaud; Pascal Claudepierre; Gabriel Baron; Yves-Dominiq 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

A one-year, phase I/IIa, open-label pilo

A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis–associated active interstitial lung disease

✍ Dinesh Khanna; Rajeev Saggar; Maureen D. Mayes; Fereidoun Abtin; Philip J. Cleme 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

Long-term efficacy and safety of inflixi

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: An open, observational, extension study of a three-month, randomized, placebo-controlled trial

✍ J. Braun; J. Brandt; J. Listing; A. Zink; R. Alten; G. Burmester; W. Golder; E. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views

The comparative one-year performance of

The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study

✍ Heiberg, Marte Schrumpf ;Koldingsnes, Wenche ;Mikkelsen, Knut ;Rødevand, Erik ;K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views